Found 12 matching trials
Evaluating the Safety, Tolerability, and Immunogenicity of a Tetravalent Dengue Vaccine (V180) in Healthy Adults Who Previously Received a Live-Attenuated Tetravalent Vaccine (TV003 or TV005) PHASE1 Dengue viruses are mosquito-borne flaviviruses. Each year, dengue viruses i...
Show More Location
Center for Immunization Research, Johns Hopkins School of Public Health
Learn More & Join Trial
Evaluation of the Protective Efficacy of TV003 or Previous Zika Infection Against Infection With ZIKV-SJRP Challenge Compared to DENV and ZIKV-naïve Controls Against Infection With ZIKV-SJRP Challenge PHASE1 Zika virus (ZIKV) is an illness people can get from mosquitoes. The infecti...
Show More Location
Center for Immunization Research, Johns Hopkins School of Public Health
Learn More & Join Trial
A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan PHASE2 The goal of this study is to determine the immunogenicity and safety of TV0...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine PHASE1 Dengue viruses can cause dengue fever and other serious health conditions, ...
Show More Location
Center for Immunization Research, Johns Hopkins School of Public Health
Learn More & Join Trial
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases PHASE4 The goal of this clinical trial is to evaluate whether the live attenuated ...
Show More Location
Hospital das Clínicas da Faculdade de Medicina da USP
Learn More & Join Trial
Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults PHASE1 Dengue viruses can cause dengue illness ranging from a mild illness to life...
Show More Location
Center for Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health
Learn More & Join Trial
Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine PHASE3 This is a randomized, multicenter, double-blind, placebo-controlled Phase I...
Show More Location
Fundação de Medicina Tropical Doutor Heitor Vieira Dourado
Learn More & Join Trial
Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart PHASE1 Dengue viruses can cause dengue fever and other more severe forms of diseas...
Show More Location
Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health
Learn More & Join Trial
Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine PHASE1 Dengue viruses can cause dengue fever and other serious health conditions, ...
Show More Location
Center for Immunization Research, Johns Hopkins School of Public Health
Learn More & Join Trial
Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine PHASE2 This is a phase II step-wise, randomized, multicenter, double-blind and con...
Show More Location
Instituto da Criança do Hospital das Clínicas da Faculdade de Medicina da USP
Learn More & Join Trial